首页> 外文期刊>The Journal of craniofacial surgery >Ultrasonic Piezoelectric Bone Surgery Combined With Leukocyte and Platelet-Rich Fibrin and Pedicled Buccal Fat Pad Flap in Denosumab-Related Osteonecrosis of the Jaw
【24h】

Ultrasonic Piezoelectric Bone Surgery Combined With Leukocyte and Platelet-Rich Fibrin and Pedicled Buccal Fat Pad Flap in Denosumab-Related Osteonecrosis of the Jaw

机译:超声波压电骨骼手术与白细胞和富含血小板的纤维蛋白和顽皮的口腔脂肪垫皮瓣在Denosumab相关骨折的下巴

获取原文
获取原文并翻译 | 示例
           

摘要

Denosumab is an antiresorptive agent that is found as a humanized antibody, which inhibits the most critical pro-osteoclastogenic factor secreted by the cancer cells and shown to be required for osteoclast formation, function, and development. A severe side effect of denosumab is the osteonecrosis of the jaw (DRONJ). There are only a few studies on DRONJ treatment in the literature. The aim of this case report is to present the successful conservative management of DRONJ observed after tooth extraction at the posterior maxilla following the discontinuation of medication. To our knowledge, this is the first DRONJ case treated with using the ultrasonic piezoelectric bone surgery combined with leukocyte and platelet-rich fibrin (L-PRF) and pedicled buccal fat pad flap (PBFP). Use of ultrasonic bone surgery in combination with L-PRF and PBFP is an alternative treatment method that can be effective in exposed bone coverage and soft tissue healing at the posterior maxillary region in DRONJ patients.
机译:Denosumab是一种抗血液的抗体剂,其作为人源化抗体,其抑制了癌细胞分泌的最关键的促骨细胞源因子,并且被证明是骨质体形成,功能和发育所必需的。 Denosumab的严重副作用是颌骨的骨折(Dronj)。在文献中只有一些关于Dronj治疗的研究。本案例报告的目的是展示在停止药物后,在后颌骨后牙齿提取后观察到的Dronj的成功保守管理。为了我们的知识,这是第一个使用超声波压电骨手术与白细胞和富含白细胞和富含血小板纤维蛋白(L-PRF)和挂钩的颊脂肪垫皮瓣(PBFP)进行处理的第一个DRONJ案例。使用超声波骨手术与L-PRF和PBFP组合使用是一种替代的治疗方法,可在Dronj患者的后上颌区域进行暴露的骨覆盖和软组织愈合。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号